2017
Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program
Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal Of Substance Use And Addiction Treatment 2017, 75: 49-53. PMID: 28237054, DOI: 10.1016/j.jsat.2016.12.014.Peer-Reviewed Original ResearchConceptsDirect acting antiviralsOpioid treatment programsPercent of patientsHCV treatmentHCV infectionActing antiviralsTreatment outcomesTreatment programOral HCV treatmentSustained virologic responseHCV treatment outcomesRoutine clinical careOngoing drug useVirologic responseRetrospective studyClinical careGeneral populationPatientsDrug useTreatmentOutcomesAntiviralsInfectionPercentPWID
2003
A Randomized Clinical Trial of a Manual-Guided Risk Reduction Intervention for HIV-Positive Injection Drug Users
Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A Randomized Clinical Trial of a Manual-Guided Risk Reduction Intervention for HIV-Positive Injection Drug Users. Health Psychology 2003, 22: 223-228. PMID: 12683743, DOI: 10.1037/0278-6133.22.2.223.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultFemaleFollow-Up StudiesHealth PromotionHIV SeropositivityHumansMaleManuals as TopicRisk FactorsRisk-TakingSubstance Abuse, IntravenousConceptsInjection drug usersDrug usersHIV-positive injection drug usersHIV-seropositive injection drug usersHIV harm reduction programsRisk behaviorsHealth promotion behaviorsRisk reduction interventionsHarm reduction programsHigh-risk behaviorsAddiction severity scoresNational AIDS Demonstration Research projectAntiretroviral medicationsMethadone maintenanceSeverity scoreClinical trialsTreatment phasePromotion behaviorsReduction interventionsTreatment entryIllicit opiatesHarm reductionDemonstration research projectsPatientsReduction programs